Marketing-authorisation holder · United States
Pharmafair
36 medicines in 1 country, as authorisation holder.
Group structure
Other companies in the group
Canada1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 36
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE400 units/gm; 3.5mg base/gm; 10,000 units/gm · Ointment | Bacitracin, Neomycin, Polymyxin b | United States | Not marketed | |
| BOROFAIR2%; 0.79% · Solution/drops | Acetic acid, Glacial, Aluminum | United States | Not marketed | |
| CARBACHOL0.01% · Solution | Carbachol | United States | Not marketed | |
| CHLOROFAIR0.5% · Solution/drops | Chloramphenicol | United States | Not marketed | |
| CHLOROFAIR1% · Ointment | Chloramphenicol | United States | Not marketed | |
| DEXAIR0.05% phosphate · Ointment | Dexamethasone | United States | Not marketed | |
| DEXAIR0.1% phosphate · Solution/drops | Dexamethasone | United States | Not marketed | |
| DEXASPORIN0.1%; 3.5mg base/gm; 10,000 units/gm · Ointment | Dexamethasone, Neomycin, Polymyxin b | United States | Not marketed | |
| DEXASPORIN0.1%; 3.5mg base/ml; 10,000 units/ml · Suspension/drops | Dexamethasone, Neomycin, Polymyxin b | United States | Marketed | 1995 |
| ERYTHROMYCIN ETHYLSUCCINATE200mg base/5ml | 400mg base/5ml · Suspension | Erythromycin | United States | Not marketed | 1981 |
| FLUOCINOLONE ACETONIDE0.01% | 0.025% · Cream | Fluocinolone acetonide | United States | Marketed | 1982 |
| GENTAFAIR0.1% base · Ointment | Gentamicin | United States | Not marketed | |
| GENTAFAIR40mg base/ml · Injectable | Gentamicin | United States | Not marketed | |
| GENTAFAIR3mg base/gm · Ointment | Gentamicin | United States | Not marketed | |
| GENTAFAIR0.3% base · Solution/drops | Gentamicin | United States | Not marketed | |
| GENTAFAIR0.1% base · Cream | Gentamicin | United States | Not marketed | |
| KAINAIR0.5% · Solution/drops | Proxymetacaine | United States | Not marketed | 1983 |
| KANAMYCIN SULFATE1gm base/3ml | 500mg base/2ml | 75mg base/2ml · Injectable | Kanamycin | United States | Not marketed | 1985 |
| MYDRIAFAIR0.5% | 1% · Solution/drops | Tropicamide | United States | Not marketed | |
| NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE400 units/gm; 1%; 3.5mg base/gm; 5,000 units/gm · Ointment | Bacitracin, Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | |
| NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN0.025mg/ml; 1.75mg base/ml; 10,000 units/ml · Solution/drops | Gramicidin, Neomycin, Polymyxin b | United States | Not marketed | |
| NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE1%; 3.5mg base/ml; 10,000 units/ml · Suspension/drops | Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | |
| NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE1%; 3.5mg base/ml; 10,000 units/ml · Suspension/drops | Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | |
| NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE1%; 3.5mg base/ml; 10,000 units/ml · Solution/drops | Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | |
| OCUMYCIN500 units/gm; 10,000 units/gm · Ointment | Bacitracin, Polymyxin b | United States | Not marketed |